Christina T. Fiske

Black race, sex, and extrapulmonary tuberculosis risk: an observational study

Christina T. Fiske, Marie R. Griffin, Erin Holt et al. · BMC Infectious Diseases · 2010 · 75 citations · Full text

Public Health, Immunology, Infectious Diseases +15

Increased Frequency of Regulatory T Cells and T Lymphocyte Activation in Persons with Previously Treated Extrapulmonary Tuberculosis

Alexandre S. de Almeida, Christina T. Fiske, Timothy R. Sterling et al. · Clinical and Vaccine Immunology · 2011 · 53 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Implementation of Bedaquiline, Pretomanid, and Linezolid in the United States: Experience Using a Novel All-Oral Treatment Regimen for Treatment of Rifampin-Resistant or Rifampin-Intolerant Tuberculosis Disease

Connie A. Haley, Marcos C. Schechter, David Ashkin et al. · Clinical Infectious Diseases · 2023 · 44 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Risk factors for treatment default in close contacts with latent tuberculous infection

Christina T. Fiske, FX Yan, Yael Hirsch‐Moverman et al. · The International Journal of Tuberculosis and Lung Disease · 2014 · 39 citations · Full text

Public Health, Infectious Diseases, Preventive Medicine +17

Long-term evaluation of clinical success and safety of omadacycline in nontuberculous mycobacteria infections: a retrospective, multicenter cohort of real-world health outcomes

Amer El Ghali, Taylor Morrisette, Sara Alosaimy et al. · Antimicrobial Agents and Chemotherapy · 2023 · 36 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +16